CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I

Tong Chen; Mercedes Barzi; Nika Furey; Hyunjae R. Kim; Francis P. Pankowicz; Xavier Legras; Sara H. Elsea; Ayrea E. Hurley; Diane Yang; David A. Wheeler; Malgorzata Borowiak; Beatrice Bissig-Choisat; Pavel Sumazin; Karl-Dimiter Bissig

doi:https://doi.org/10.1016/j.jhepr.2025.101327

CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I

Identifier:nobleid.org/w1/20260418/47DF1FD8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/47DF1FD8.svg?ark=w1%2F20260418%2F47DF1FD8)](https://nobleid.org/work/w1/20260418/47DF1FD8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Beatrice Bissig-Choisat

Pavel Sumazin

Karl-Dimiter Bissig

Claim authorship of this work

CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I

Identifier:nobleid.org/w1/20260418/47DF1FD8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/47DF1FD8.svg?ark=w1%2F20260418%2F47DF1FD8)](https://nobleid.org/work/w1/20260418/47DF1FD8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Beatrice Bissig-Choisat

Pavel Sumazin

Karl-Dimiter Bissig

Claim authorship of this work